相似文献/References:
[1]叶林华,袁苏徐.紫杉醇联合卡培他滨治疗晚期胃癌疗效观察[J].新乡医学院学报,2011,28(01):102.
[2]张海鹏,鲍启德,周利霞,等.吉非替尼联合奥沙利铂对人肝癌细胞SMMC-7721增殖和凋亡的影响[J].新乡医学院学报,2019,36(12):1115.[doi:10.7683/xxyxyxb.2019.12.004]
ZHANG Hai-peng,BAO Qi-de,ZHOU Li-xia,et al.Effect of gefitinib combined with oxaliplatin on proliferation and apoptosis of human hepatoma cell SMMC-7721[J].Journal of Xinxiang Medical University,2019,36(09):1115.[doi:10.7683/xxyxyxb.2019.12.004]
[3]熊万成,平贯芳,贺德栋,等.雷公藤甲素对人结直肠癌细胞奥沙利铂耐药性的影响[J].新乡医学院学报,2023,40(7):613.[doi:10.7683/xxyxyxb.2023.07.003]
XIONG Wancheng,PING Guanfang,HE Dedong,et al.Effect of triptolide on resistance of human colorectal cancer cell line to oxaliplation[J].Journal of Xinxiang Medical University,2023,40(09):613.[doi:10.7683/xxyxyxb.2023.07.003]
[4]王荦楠杨 萌崔艳慧张清琴,苗战会李小瑞,寇小格.奥沙利铂联合卡培他滨治疗晚期肝细胞癌的疗效及安全性 [J].新乡医学院学报,2012,29(10):787.